TURTON SIMON enters BIODEXA PHARMACEUTICALS PLC with 2.77K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001214659-26-003420
2.77K
Baseline shares
100% direct
2.77K
Direct ownership
1 position
288.00
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned2.77K
Total
2.77K direct2.77K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 2.77K | Direct |
| Total | 2.77K | 2.77K direct |
Derivative Holdings1
Stock Option (right to buy)
DirectUnderlying security
American Depositary Shares
Underlying shares
288.00
Shares owned
N/A
Exercise price
475
Expiration
—
Exercise window
—
Total
Underlying
288.00
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | American Depositary Shares | 475 | — | — | 288.00 | N/A |
| Total | 288.00 | 0.00 | ||||